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Regeneration is the unmatched liver ability for recovering its functional mass after tissue lost. 
Leukotrienes (LT) are a family of eicosanoids with the capacity of signaling to promote proliferation. 
We analyzed the impact of blocking LT synthesis during liver regeneration after partial hepatectomy 
(PH). Male Wistar rats were subjected to two-third PH and treated with zileuton, a specific inhibitor of 
5-lipoxygenase (5-LOX). Our first find was a significant increment of intrahepatic LTB4 during the first 
hour after PH together with an increase in 5-LOX expression. Zileuton reduced hepatic LTB4 levels at the 
moment of hepatectomy and also inhibited the increase in hepatic LTB4. This inhibition produced a delay 
in liver proliferation as seen by decreased PCNA and cyclin D1 nuclear expression 24 h post-PH. Results 
also showed that hepatic LTB4 diminution by zileuton was associated with a decrease in NF-ĸB activity. 
Additionally, decreased hepatic LTB4 levels by zileuton affected the recruitment of neutrophils and 
macrophages. Non-parenchymal cells (NPCs) from zileuton-treated PH-rats displayed higher apoptosis 
than NPCs from PH control rats. In conclusion, the present work provides evidences that 5-LOX 
activation and its product LTB4 are involved in the initial signaling events for liver regeneration after PH 
and the pharmacological inhibition of this enzyme can delay the initial time course of the phenomenon.
The liver has the exceptional ability to regenerate after surgical removal or a toxic insult. Liver regeneration fol-
lowing partial hepatectomy (PH) is an extremely complex and fine-orchestated process. Many signaling cascades 
are associated with this phenomenon, including cytokines, growth factors, microRNAs, extracellular matrix 
remodeling signals, which are turned on and off at particular times. After a resection, a complex process begins 
to restore lost liver mass; at the same time and during the regenerative process, the organ provides full assistance 
to body homeostasis1–3. Clinically, the procedure is performed in humans for resecting solitary liver tumors, 
repairing injury, as well as for living-donor liver transplantation. The most widely used model in experimental 
hepatology for studying regenerative liver growth is two-thirds PH in rodents, in which liver initial functional 
mass is restored in few days4.
Eicosanoids are lipid mediators generated from arachidonic acid, which is released by phospholipase A2 
enzyme from membrane phospholipids. The three major pathways for eicosanoids synthesis are lipoxygenase 
(LOX), cyclooxygenase (COX), and epoxygenase. Leukotrienes (LT) are synthesized via 5-lipoxygenase (5-LOX) 
pathway, which generates biologically inactive leukotriene A4 (LTA4)5. LTA4 hydrolase (LTA4-H) catalyzes the 
hydrolysis of LTA4 to produce leukotriene B4 (LTB4). A second LTA4 metabolic pathway is the production of 
leukotriene C4 (LTC4) by the enzyme LTC4 synthase (LTC4-S)6. Despite LT were firstly described to be produced 
by leukocytes, it is now known that they are produced by other cell types. In liver, Kupffer cells are the only cell 
type endowed with a metabolically active 5-LOX pathway7.
LTB4 was classically described as a pro-inflammatory mediator, promoting antimicrobial defense and modu-
lating the immune system. When LTB4 is formed in excess or improperly, it can participate in the pathogenesis of 
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chronic inflammatory conditions8. In this sense, 5-LOX inhibition is a strategy for stopping LTB4-driven disease 
progression. Zileuton is a selective and reversible 5-LOX inhibitor. It is the only commercially available 5-LOX 
inhibitor used for inflammatory airway diseases treatment. After oral administration in humans, zileuton is rap-
idly absorbed, and its plasma concentration peaks at 1–3 h after dose and correlates with LTB4 inhibition9,10.
On the other hand, it is known that LT promote proliferation of tumor cells. An increase in 5-LOX expression 
and activity was described in certain cancers, while its inhibition was found to cause apoptosis11. Interestingly, 
this proliferative role has been essentially attributed to LTB412–15. Particularly in hepatocellular carcinoma HepG2 
cells, LTB4 acts as an activator of NF-kB, a critical factor for cell survival16. In liver proliferation, it has been high-
lighted the association between genes related to lipid metabolism and liver regeneration after PH. Particularly, 
genes that promote LT synthesis, including ALOX5, are up-regulated during the initial times after PH in rat 
liver17. However, the connection between this increase and liver regeneration was not explored. The aim of pres-
ent study was to evaluate the changes in LT producing-enzymes during liver regeneration and the participation of 
LT in the phenomenon. Using the specific 5-LOX inhibitor, zileuton, we analyzed the impact of blocking the LT 
producing pathway during liver proliferation after PH.
Materials and Methods
Chemicals. Zileuton was obtained from Hangzhou Starshine Pharmaceutical Co., LTD. Collagenase type 
IV from Clostridium histolyticum was purchased from Sigma-Aldrich. Antibodies against Cyclin D1, Lamin 
A/D, 5-LOX, LTA4-H, LTC4-S, CD68, Bax, and Bcl-2 used for western blot studies were from Santa Cruz 
Biotechnology. Anti- Ikβ-α was purchased from Cell Signalling Technologies, anti-CD11b from Abcam, anti-
CLEC 4F from R&D Systems and anti-β-actin was from Sigma.
Animals and surgery. Adult male Wistar rats weighing 250–280 g were maintained in a room at constant 
temperature with a 12 h light-dark cycle, with food and water supplied ad libitum. Animal work was performed at 
the Institute of Experimental Physiology (IFISE, Faculty of Biochemical and Pharmaceutical Sciences, CONICET, 
National University of Rosario). Experimental protocols were performed according to the National Institutes of 
Health guide for the care and use of Laboratory animals (NIH Publication 25–28, revised 1996) and approved by 
the local animal care and use committee: “Bioethical Committee for the Care and Use of Laboratory Animals” 
from Faculty of Biochemical and Pharmaceutical Sciences of the National University of Rosario (Permission 
108/2014, FBioyF, UNR). Animals were anesthetized with ketamine/xylazine (100 and 3 mg/Kg body weight, 
respectively) and two-thirds PH was performed as previously described by Higgins and Anderson18. Also, a sim-
ulated surgery was carried out in control animals (sham group, n = 15). Vehicle (saline solution/ethanol, n = 18) 
or zileuton at the doses of 10 (n = 4) or 40 mg/Kg body weight (n = 18) were administered by gavage two hours 
before PH in order to obtain the maximal 5-LOX inhibition at the time of surgery. Zileuton dose of 10 mg/Kg was 
used in rats to treat inflammatory injuries in several organs such as lung and kidney19,20; whereas 40 mg/Kg zileu-
ton was comparable to human daily intake for the treatment of airway inflammatory conditions10. Animals were 
anesthetized and euthanized by exsanguination at 1, 5, 24 and 48 h post-PH and blood samples were collected 
and livers were removed to be processed (n = 6 for animals euthanized at 24 h post-PH, and n = 4 for animals 
euthanized at 1, 5 and 48 h post-PH).
Liver weight/body weight ratio [(liver weight/body weight) × 100] was calculated and used as a measurement 
of total volume of regenerating liver at the different times post-PH.
Enzymes activities determination. Alanine and aspartate aminotransferases (ALT and AST, respectively) 
and alkaline phosphatase (ALP) were determined spectrophotometrically in fresh serum by commercial kits 
(Wiener Lab, Rosario, Argentina).
Histology and immunohistochemical studies. Liver tissue fixed in 10% neutral buffered formalin and 
embedded in low melting paraffin was used for immunohistochemical detection of proliferating cell nuclear anti-
gen (PCNA), cyclin D1 and myeloperoxidase (MPO). Liver sections were deparaffinized, rehydrated and endoge-
nous peroxidase was blocked. Slides were boiled in sodium citrate buffer pH 6 for antigen retrieval and incubated 
overnight with the primary antibodies (anti-PCNA, Santa Cruz; anti-cyclin D1, Abcam and anti-MPO, Dako). 
CytoScan HRP Detection System (Cell Marque) was used for detection of positive labelled cells. The PCNA pro-
liferative index was defined as the number of proliferative cells (in G1, S, G2 and M phases) per 100 hepatocytes 
counted in ten high-power fields. Proliferating hepatocytes in each phase of the cell cycle were also determined 
by a blinded histological analysis based on the specific PCNA staining patterns, as previously described21,22. 
MPO-positive cells were counted in 20 randomly selected fields (200X).
Liver sections were also assessed for histological changes by Hematoxylin and Eosin (H&E) staining at 24 h 
post-PH. Mitotic figures were evaluated by examination of H&E sections. Number of mitotic figures was counted 
in 20 representative 200X fields.
For immunofluorescence studies, cryostat liver sections were fixed with ice-cold 4% paraformaldehyde, 
permeabilized with 0.2% Triton X100 in PBS, blocked and overnight incubated with anti-rat neutrophil 
FITC-conjugated antibody (LS-C348005, LSBio). Detection of bound antibody was achieved by immunofluores-
cence in a Nikon C1 Plus microscope. Neutrophils were counted in 20 randomly selected fields.
ELISA assay for hepatic LTB4 and LTC4 quantification. LTB4 and LTC4 were determined in liver 
extracts with commercial ELISA kits (NEOGEN Corporation). LT were purified in C18 Sep-Pak® light Columns 
(Waters® Corporation), eluted with ethyl acetate (LTB4) or methanol (LTC4), evaporated with nitrogen gas and 
dissolved in the ELISA’s extraction buffer. The ELISAs were performed as indicated in the product datasheet.
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Western blot analysis. Liver tissue lysates and mitochondrial and nuclear extracts were prepared as previ-
ously described21,23. Proteins were quantified according to Lowry et al.24 and western blot studies were performed 
as formerly described21.
RNA isolation, cDNA synthesis and RT-qPCR analysis. RNA was isolated from rat liver tissue by the 
TriZOL method (Life Technologies Inc.) according to the manufacturer’s instructions. One microgram of total 
RNA was treated with DNase I (Thermo Fisher Scientific) and cDNA was made using an oligo-dT primer and 
M-MLV reverse transcriptase (Promega). PCR assay was performed using an Mx3000P Real-Time Thermocycler 
(Stratagene) with EvaGreen® dye (HOT FIREPol® EvaGreen® qPCR Mix Plus (ROX); Solis BioDyne). Primer 
sequences are shown in Supplementary Information. PCR reactions were initiated by incubation at 95 °C for 
12 min, followed by 40 cycles at 95 °C for 15 s, 60 °C for 30 s and 72 °C for 30 s. Relative changes in gene expression 
were determined by using the 2−ΔΔCt method25.
NF-kB activity assay. The NF-kB activity was determined in nuclear extracts by a colorimetric reaction 
using NFκB p50/p65 EZ-TFA Transcription Factor Assay (Millipore Corporation), following the instructions 
manual of the kit.
Liver leukocytes isolation. Liver leukocytes were isolated as previously described, with slight modifica-
tions26. Briefly, 5 h after hepatectomy, livers from PH (n = 4) and PHZi rats (n = 4) were pressed through a 100 µm 
cell strainer (Jet Bio-Fil). Liver cells were suspended in Hank’s Balanced Salt Solution (HBSS) and centrifuged at 
500 g for 5 min. Pellets were re-suspended in 35% Percoll (Sigma) containing 100 U/mL heparin and centrifuged 
at 800 g for 20 min at room temperature. The cell pellets containing leukocytes were collected and re-suspended 
in red blood cell lysis solution. After 5 min incubation on ice, cells were washed twice in HBSS. For analysis of 
neutrophil markers MPO and elastase, 106 cells were subjected to RNA isolation and RT-qPCR, as previously 
described.
Isolation of non-parenchymal cells and hepatocytes. Non-parenchymal cells (NPCs) and hepato-
cytes were isolated from sham (n = 3) and PH and PHZi rats 1, 5, and 24 h (n = 4 per group at each time) after sur-
gery as previously described, with few modifications27. Briefly, animals were anesthetized with ketamine/xylazine 
and after catheterization of the portal vein, the liver was perfused with collagenase type IV. NPCs were separated 
from hepatocytes and counted, and cell viability was analyzed by trypan blue exclusion test. Purity of NPCs frac-
tion from hepatocytes markers was checked by western blot (data not shown).
Caspase-3 activity. Caspase-3 activity was determined in lysates of hepatocytes and NPCs using Enz Chek 
Caspase-3 Assay kit #1 (Molecular Probes Inc, Eugene, OR, USA), following the manufacturer’s suggestions.
Annexin V/propidium iodide assay. NPCs (1,5 × 106 cells) were used to assess the apoptotic cell death by 
AnnexinV/propidium iodide staining (FITC Annexin V Apoptosis Detection Kit II; BD Biosciences) coupled to 
flow cytometry analysis (BD FACSAria™ II cell sorter flow cytometer, BD Biosciences), as previously described28.
Statistical analysis. Results are expressed as mean ± SEM. Statistical significance was evaluated by unpaired 
two- tailed Student’s test or by one-way ANOVA followed by Tukey test. Differences were considered significant 
when p < 0.05.
Results
Hepatic enzymes activities did no change after oral administration of zileuton. The activities of 
ALT, AST and ALP increased after PH and peaked 24 h post-PH. On the other hand, there was no statistical dif-
ference between the groups treated with vehicle or zileuton, indicating that zileuton dosage did not affect serum 
markers of liver function (Table 1). Indeed, zileuton-treated sham animals showed no difference in the activities 
of these liver markers as in any other parameter measured further on, thus, this group will not be included in the 
description of the results.
Experimental group AST (U/L) ALT (U/L) ALP (U/L)
Sham 232,5 ± 24,0 162,2 ± 36,8 260,8 ± 52,3
1 h post-PH
PH 201,7 ± 38,5 146,0 ± 27,0 223,0 ± 24,1
PHZi 174,0 ± 50,0 131,2 ± 33,9 258,3 ± 30,4
5 h post-PH
PH 784,0 ± 159,7* 1376,7 ± 269,8* 427,1 ± 38,8*
PHZi 966,0 ± 175,1* 1886,9 ± 139,9* 310,6 ± 69,5*
24 h post-PH
PH 1211,0 ± 300,3* 2512,9 ± 197,3* 375,7 ± 20,7*
PHZi 1213,7 ± 200,5* 1946,0 ± 23,0* 398,5 ± 67,4*
48 h post-PH
PH 410,8 ± 101,8* 518,9 ± 208,8* 524,1 ± 33,6*
PHZi 673,0 ± 84,2* 703,7 ± 138,0* 484,3 ± 55,2*
Table 1. AST, ALT and ALP enzyme activities. AST, ALT and ALP enzyme activities in plasma samples of sham 
and partial-hepatectomized animals treated with vehicle (PH) or zileuton 40 mg/Kg body weight (PHZi). Data 
were expressed in units per litre of sample (U/L) and represent media ± SEM (n ≥ 4). *p < 0.05 vs. Sham.
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Zileuton reduced liver proliferation after PH. In order to establish if liver regeneration was affected 
by zileuton, we first analyzed liver weight to body weight (LW/BW) ratio after PH. LW/BW ratio was signifi-
cantly reduced in rats treated with 40 mg/Kg zileuton at 24 and 48 h post-PH, showing a decrease of 15 and 10%, 
respectively (Fig. 1a). Next, we analyzed PCNA-positive hepatocytes by immunohistochemistry 24 h post-PH, 
time in which rat hepatocytes displayed an initial peak of DNA synthesis29. Figure 1b shows representative 
images of PCNA staining, with a clear decrease in PCNA-positive hepatocytes in PH-rats treated with 40 mg/
Kg zileuton. Proliferative index analysis 24 h post-PH showed a significant decrease in PH-animals treated with 
40 mg/Kg zileuton, with less hepatocytes in each phase of the cell cycle (Fig. 1c,d). In accordance, the number of 
mitotic figures was reduced in PH-rats treated with zileuton (Fig. 1e). As expected, and supporting these findings, 
immunoblotting and immunohistochemistry for cyclin D1 24 h post-PH showed that nuclear levels of cyclin D1 
increased in the PH-rats, but were notably reduced in zileuton-treated PH-rats (Fig. 1f,g). As 10 mg/Kg zileuton 
had effect neither on LW/BW ratio nor on liver proliferation 24 h after PH, we continued using 40 mg/Kg zileuton 
throughout the study.
On the other hand, there was no difference in the proliferation index between zileuton and vehicle-treated PH 
groups 48 h post-PH (Fig. 1h), indicating a partial recovery of regeneration. Interestingly, there was an accumu-
lation of cells in the S phase (Fig. 1i), which could be a consequence of the delay in proliferation. In accordance, 
there was no significant difference in LW/BW ratio 168 h after surgery (data not shown), indicating that zileuton 
affects only the initial stage of regeneration, but final liver weight recovery can be reached.
Clearly, a single dose of 40 mg/Kg zileuton 2 h before PH delays the initial time course of liver regeneration, 
significantly affecting proliferation 24 h post-surgery, the time in which hepatocytes DNA synthesis peaks1. At 
later times, the delay in liver proliferation is rescued. Despite additional doses would be necessary to determine if 
a sustained zileuton treatment impacts on final liver recovery, the results presented in this work using zileuton for 
inhibition of 5-LOX at the onset of liver regeneration shows that 5-LOX pathway can take part in the regenerative 
process.
Additionally, the specificity of the role of LTB4 in liver regeneration after PH was established using an 
inhibitor of LTA4-H. PCNA-positive hepatocytes 24 h post-PH significantly decreased in animals treated with 
LTA4-H inhibitor, confirming that the specific inhibition of hepatic LTB4 affected liver regeneration after PH 
(Supplementary Fig. 1).
Hepatic LTB4 levels augmented 1 h after PH and zileuton treatment affected this increase. To 
determine the effectiveness of zileuton in the inhibition of hepatic 5-LOX activity, we measured the levels of the 
main LT (LTB4 and LTC4) in the removed liver lobules (maximum zileuton serum concentration and time 0 h for 
hepatectomy). Figure 2a shows that animals treated with zileuton exhibited more than 50% reduction in hepatic 
LTB4 levels, which means that at the time of surgery LTB4 levels were below control levels, with no significant 
changes in LTC4 levels.
Surprisingly, hepatic LTB4 levels showed a two-fold increase 1 h post-PH compared to the sham group. Five 
hours post-PH LTB4 levels showed a non-significant increase, and 24 h post-PH LTB4 levels were significantly 
reduced, as seen in Fig. 2b. Zileuton administration partially blocked the increase in hepatic LTB4 1 h post-PH. 
By contrast, the amount of hepatic LTC4 did not change at early times, but its levels were reduced 24 h post-PH 
(Fig. 2c).
5-LOX along with other enzymes of LT synthesis changed their expression during liver regener-
ation. Consistent with hepatic levels of LTB4 1 h post-PH, we observed an increase in 5-LOX protein expres-
sion at that time, with no changes in mRNA levels (Fig. 3a,b). The difference between the expression of mRNA 
and protein may be due to the fact that increased protein expression could be regulated by a post-transcriptional 
mechanism or because 5-LOX mRNA could increase at shorter times than 1 hour post-PH. At longer times, 
protein levels of 5-LOX returned to those observed in sham animals, with a trend to be reduced 24 h post-PH. 
Besides, 5-LOX mRNA expression was significantly reduced 5 and 24 h post-PH. Remarkably, 5-LOX induc-
tion during the initial times of liver regeneration after PH seems to be a general event in rodents since we 
observed an increase in 5-LOX protein and mRNA levels also in mice 2 h after PH, becoming lower at later times 
(Supplementary Fig. 2a,b).
LTA4-H mRNA expression was reduced after PH at all the studied times. Protein levels of this enzyme tended 
to be diminished, although they were only significantly different 5 h post-PH (Fig. 3c,d). Likewise, LTC4-S expres-
sion remained low throughout the regeneration study (Fig. 3e,f). These patterns were similar to those observed 
in mice (Supplementary Fig. 2c–f).
5-LOX inhibition by zileuton reduced the activation of the transcription factor NF-kB. During 
the first hours after PH (priming phase), NF-kB transcription factor is activated in hepatocytes and NPCs. Upon 
activation, NF-kB induces the production of interleukin-6 (IL-6), a cytokine that mediates hepatocytes prolif-
eration4. Thus, we sought to evaluate whether 5-LOX inhibition by zileuton affected or not NF-kB pathway. As 
expected, the activity of this protein in liver nuclear extracts was increased 1 h post-PH, but it was significantly 
reduced in liver nuclear extracts from rats treated with zileuton (Fig. 4a). Also, levels of the inhibitor of NF-kB, 
Ikβ-α, were significantly increased in the animals treated with zileuton (Fig. 4b).
Additionally, we determined IL-6 mRNA levels in NPCs 1 hour after PH. Results are shown in Fig. 4c. IL-6 
mRNA levels significantly increased after PH and this increment was partially blocked by zileuton, indicating that 
IL-6 production by macrophages can be affected by zileuton treatment. This result was in accordance with the 
decrease in NF-kB activation observed in this experimental group. Additionally, hepatic mRNA levels of TNF-α, 
IL-1β and IL-10 were analyzed and they did not show differences between PH and PHZi groups (data not shown).
5Scientific RepoRtS |         (2019) 9:18176  | https://doi.org/10.1038/s41598-019-54652-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 1. Effect of oral administration of zileuton in liver proliferation in PH-rats. (a) Liver weight to body 
weight (LW/BW) ratio 24 and 48 h post-PH. (b) Representative images of Proliferating Cell Nuclear Antigen 
(PCNA) immunohistochemistry from rat liver tissue 24 h post-PH obtained by optical microscopy (200X). (c) 
Proliferation Index (PI) determined by PCNA staining 24 h post-PH. PI was calculated as the number of cells in 
G1, S, G2 and M phases of the cell cycle per 100 hepatocytes. (d) Number of PCNA-positive cells in each phase 
of the cell cycle per 100 hepatocytes 24 h post-PH. (e) Quantification of mitotic figures by analysis of H&E 
images 24 h post-PH. Analysis of cyclin D1 24 h post-PH by (f) immunoblotting studies in liver nuclear extracts 
and (g) immunohistochemistry (100X). Selected lanes were cropped from different parts of the same gel and 
they are shown after cropping, aligning and separating them by white space. Full-length blots are available in 
Supplementary Information. (h) Proliferation Index determination by PCNA immunohistochemistry in 48 h 
post-PH rat liver tissue. (i) PCNA-positive cells in each phase of the cell cycle per 100 hepatocytes 48 h post-PH. 
Sh: sham animals, PH: partial-hepatectomized animals treated with vehicle, PHZi10: PH-animals treated 
with zileuton 10 mg/Kg body weight, PHZi40: PH-animals treated with zileuton 40 mg/Kg body weight. Bars 
represent mean ± SEM (n ≥ 4 per experimental group). *p < 0.05 vs. Sh, #p < 0.05 vs. PH.
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After PH, multiple signaling mechanisms are turned on and off at particular times to ensure optimal liver 
regeneration30. Among these pathways, Wnt/β-catenin was explored since it is turned on when LTB4 levels are 
increased after PH. Interestingly, inhibition of hepatic LTB4 by zileuton decreased Wnt2 mRNA expression in 
Figure 2. Hepatic LTB4 and LTC4 levels detected by ELISA. (a) LTB4 and LTC4 levels in the removed lobes 
(time zero for surgery and 2 h after zileuton administration). (b) LTB4 and (c) LTC4 hepatic levels at 1, 5 and 
24 h post-partial hepatectomy (PH) in animals treated with vehicle or zileuton 40 mg/Kg body weight. Pre-PH: 
Removed tissue from animals treated with vehicle, Pre-PHZi40: Removed tissue from animals treated with 
zileuton 40 mg/Kg body weight, Sh: sham animals, PH: partial-hepatectomized animals treated with vehicle, 
PHZi: PH-animals treated with zileuton 40 mg/Kg body weight. Bars represent mean ± SEM (n = 4 per 
experimental group). *p < 0.05 vs. Sh or Pre-PH, #p < 0.05 vs. PH for each time.
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NPCs and increased hepatic inactive β-catenin levels (Supplementary Fig. 3). These results are indicative that 
zileuton treatment impacts on Wnt/β-catenin signaling after PH.
Reduced hepatic LTB4 levels by zileuton affected the recruitment of neutrophils. It was reported 
that after PH there is an increase in liver leukocytes, including neutrophils and macrophages. Particularly, neutro-
phils transiently increase in the liver during the first hours post-PH31. As LTB4 is a potent chemoattractant agent 
Figure 3. mRNA and protein expression of main enzymes for LT synthesis in rat liver 1, 5 and 24 h post-PH in 
animals treated with vehicle or zileuton. RT-qPCR of (a) 5-LOX, (c) LTA4-H and (e) LTC4-S. Immunoblotting 
of (b) 5-LOX, (d) LTA4-H and (f) LTC4-S. Selected lanes were cropped from different gels and they are shown 
after cropping, aligning and separating them by white space. Full-length blots are available in Supplementary 
Information. The amount of every protein band was corrected by β-actin but not shown in order to avoid a more 
complex image. Sh: sham animals, PH: partial-hepatectomized animals treated with vehicle, PHZi: PH-animals 
treated with zileuton 40 mg/Kg body weight. Bars represent mean ± SEM (n = 4 per experimental group). 
*p < 0.05 vs. Sh, #p < 0.05 vs. PH for each time.
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for neutrophil granulocytes, we analyzed the impact of reducing hepatic LTB4 levels by zileuton in neutrophils 
recruitment during regeneration. Analysis of MPO-positive cells showed a significant increase in regenerating 
livers 1 and 5 h post-PH (Fig. 5a), as previously reported31. Zileuton treatment interfered with neutrophils recruit-
ment, as shown by decreased MPO-positive cells in HPZi animals. In accordance, MPO and elastase mRNA 
expression in isolated liver leukocytes was reduced after zileuton treatment (Fig. 5c,d). Finally, immunofluores-
cence studies using a specific antibody against rat neutrophils displayed a decrease in neutrophils recruitment in 
liver tissue from zileuton treated rats (Fig. 5e,f).
Inhibition of 5-LOX activity by zileuton incremented apoptosis in NPCs after PH. As NPCs are 
important cytokine and other mediators-producing cells necessary to start and finish liver regeneration, and 
because Kupffer cells are the only liver cells that possess a metabolically active 5-LOX pathway7, we analyzed if 
5-LOX inhibition affected these cells. First, we studied CLEC4F, a c-type lectin exclusively expressed by resident 
Kupffer cells32. Figure 6a shows this protein was noticeably reduced in PH animals 24 h post-surgery. At this time, 
these protein levels were even more reduced in the PH-rats treated with zileuton. Also, CD68 protein levels were 
reduced 24 h post-PH and even more reduced in the NPCs from animals treated with zileuton (Fig. 6b). By con-
trast, CD11b levels were augmented in the PH-animals but reduced in the animals treated with zileuton (Fig. 6c). 
At 1 and 5 h post-PH, CLEC4F, CD68 and CD11b protein levels did not show differences between PH and PHZi 
NPCs (data not shown).
Finally, we studied apoptosis in NPCs 24 h after PH by annexin/propidium iodide staining and also by meas-
uring activity and protein expression of caspase-3. Interestingly, apoptosis of NPCs was reduced in regenerating 
livers compared to sham operated animals. However, this decrease in apoptosis was not observed in NPCs from 
zileuton treated PH-rats, showing a significant increment in apoptosis compared with vehicle treated PH-rats 
(Fig. 7a–c).
Discussion
The liver has the unmatched capacity for growing back after tissue loss by toxic insults, viral infections or 
trauma (compensatory hyperplasia). This feature, known as liver regeneration, allows split-liver transplantation, 
living-donor transplantation and segmental resections for hepatic and metastatic tumors. A better understand-
ing of the many players that cooperate to initiate, sustain and complete liver regeneration is necessary for the 
comprehension of clinical situations in which liver regeneration is deficient or failed. In this context, the last 
decades brought a great progress in understanding the kinetic and molecular machinery involved in successful 
liver regeneration after loss of hepatic mass by two-thirds PH in rodents2,30.
The present study provides, for the first time, clear evidences that 5-LOX and LT, particularly LTB4, partici-
pate in the regenerative phenomenon after PH in rodents. Previous work of Urade et al.33 analyzed the effect of 
5-LOX inhibition in liver regeneration after PH and, contrary to our results, the authors reported that inhibition 
of 5-LOX improved liver regeneration. However, in that work authors combined PH with obstructive jaundice 
and treatment with 5-LOX inhibitor improved liver regeneration because it reduced the inflammatory response 
induced by bile duct ligation. In fact, they attributed the improvement in liver regeneration to the reduction 
in LTC4 levels which contribute to hepatic injury during bile flow obstruction. Furthermore, authors adminis-
tered 5-LOX inhibitor after surgery, so it would not necessarily affect the increase of hepatic LTB4 levels during 
Figure 4. Analysis of zileuton effect on NF-κB activation 1 h post-PH. (a) NF-κB binding activity measured 
with a commercial kit. (b) Immunoblotting of the NF-κB inhibitor, IκB-α, in total lysates. (c) Analysis of 
mRNA expression by RT-qPCR of IL-6. Selected lanes were cropped from different parts of the same gel and 
they are shown after cropping, aligning and separating them by white space. Full-length blots are available in 
Supplementary Information. Sh: sham animals, PH: partial-hepatectomized animals treated with vehicle, PHZi: 
PH-animals treated with zileuton 40 mg/Kg body weight. Bars represent mean ± SEM (n = 4 per experimental 
group). *p < 0.05 vs. Sh, #p < 0.05 vs. PH.
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the first hours post-PH. In other experimental models of hepatic chemical injury with a significant necroin-
flammatory damage, 5-LOX inhibition or deletion was also beneficial as LT are mediators of inflammation and 
cell damage34,35. On the other hand, in hepatic ischemia/reperfusion injury it was shown that deletion of LTB4 
receptor 1 (BLT1) delayed liver repair36. Despite many human liver diseases progress in association with innate 
Figure 5. Effect of zileuton treatment on neutrophils recruitment after partial hepatectomy. (a) 
Mieloperoxydase (MPO)-positive cells quantification in liver tissue from Sh, PH and PHZi rats at 1 and 5 h 
post-PH. (b) Representative images of MPO immunostaining 5 h post-PH obtained by optical microscopy 
(400X). Analysis of mRNA expression of (c) MPO and (d) elastase in isolated liver leukocytes 5 h after 
PH. (d) Quantification of recruited liver neutrophils 5 h post-PH assessed by immunofluorescence and 
confocal microscopy. (e) Representative images from immunofluorescence detection of neutrophils (100X 
magnification). Sh: sham animals, PH: partial-hepatectomized animals treated with vehicle, PHZi: PH-animals 
treated with zileuton 40 mg/Kg body weight. Bars represent mean ± SEM (n = 4 per experimental group). 
*p < 0.05 vs. Sh, #p < 0.05 vs. PH.
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immunity and necrosis, the study of liver regeneration after PH has the advantage of providing information about 
the regenerative process relevant only to liver tissue2,4. In this context, our study shows a significant increment 
of hepatic LTB4 levels during the first hours after PH together with an increase in 5-LOX expression. Both incre-
ments occurred during the priming phase of liver regeneration and were not observed at later time; still more 
hepatic LTB4 and 5-LOX expression were significantly reduced at that time. Interestingly, we can consider this 
new finding as a general event in rodent liver regeneration as it was observed both in rat and mouse liver tissue. 
Moreover, hepatic LTC4 levels and LTC4-S expression did not show increments at the studied times. On the con-
trary, they were significantly reduced. Despite we did not explore the mechanisms of LTC4-S regulation, it seems 
to be reasonable that during liver regeneration hepatic cysteinil LT are maintained at levels that do not cause 
hepatic injury, given that this kind of eicosanoids are clearly related to tissue damage in liver pathologies such as 
cholestasis and cirrhosis37,38. Additionally, the pattern of 5-LOX protein expression is opposite to that observed 
and already reported for COX-2 expression during liver regeneration, which is maintained low at early times 
post-PH but it is augmented at later times39. In our study, the profile changes of COX-2 during liver regeneration 
were not affected by zileuton (data not shown). Regarding this concern, despite it has been previously described 
that zileuton may affect prostaglandins production under certain circumstances40, other publications revealed 
that zileuton did not change the levels of COX-2 products, even at high doses41.
On the other hand, zileuton significantly reduced hepatic LTB4 levels at the moment of hepatectomy and also 
partially inhibited the increase in hepatic LTB4 content 1 h post-PH. This inhibition produced a delay in the time 
course of liver proliferation as seen by reduced LW/BW ratio and decreased PCNA and cyclin D1 24 h post-PH, 
time in which hepatocyte DNA synthesis peaks in rats, unlike mice in which liver regeneration is more retarded 
(DNA synthesis peaks at 48 h). The delay in liver regeneration in zileuton-treated rats was partially recovered 
48 h post-PH. At that time, whereas proliferative index was comparable between groups, LW/BW ratio was not 
completely recovered.
It has been extensively reported that 5-LOX and its metabolite LTB4 can promote cancer cells proliferation. 
LTB4 levels are increased in human colon and prostate cancers; also 5-LOX and LTB4 receptor expressions are 
increased in human pancreatic cancer. Moreover, reduction in LTB4 synthesis by inhibition of LTA4-H reduced 
esophageal adenocarcinoma development in rats42. Particularly in liver cancer, 5-LOX and LTB4 are capable of 
increasing the transcriptional activity of NF-ĸB through the up-regulation of expression and nuclear translocation 
of NF-ĸB p65 and the increase of phosphorylation level of ĸBα inhibitor (IĸBα)16. In line, our results showed that 
the diminution in hepatic LTB4 by zileuton is associated with a decrease in the induction of NF-ĸB activity after 
PH. Moreover, treatment with zileuton maintained IĸBα protein levels to those observed in non-operated animals.
Ohkubo et al. showed that LTB4 signaling facilitates liver repair after ischemia/reperfusion injury through 
activation of epidermal growth factor (EGF) signaling36. So, we explored the impact of inhibiting hepatic LTB4 
by zileuton on EGF signaling and no differences were observed between PH and PHZi groups (data not shown), 
indicating that EGF is not involved in zileuton effects.
Considering the established role of LTB4 as an attractant of leukocytes43 and the fact that the recruitment of 
the innate immune cells contributes to liver regeneration30, it is possible that the early, transient and controlled 
increase in hepatic LTB4 after PH favors the recruitment of neutrophils and monocytes/macrophages. So, we 
studied if reduced hepatic LTB4 levels by zileuton affected the recruitment of these cells. Results showed that 
zileuton treatment interfered with the recruitment of neutrophils that takes place in the first hours post-PH 
(Fig. 5) and also interferes with the recruitment of macrophages that takes place at later time (Fig. 6).
Figure 6. Analysis of macrophages/Kuppfer cells markers in liver NPCs population. Immunoblotting of (a) 
CLEC4F (b) CD68 and (c) CD11b in NPCs lysates 24 h post-PH. Selected lanes were cropped from different 
parts of the same gel and they are shown after cropping, aligning and separating them by white space. Full-
length blots are available in Supplementary Information. Sh: sham animals, PH: partial-hepatectomized 
animals treated with vehicle, PHZi: PH-animals treated with zileuton 40 mg/Kg body weight. Bars represent 
mean ± SEM (n = 4 per experimental group). *p < 0.05 vs. Sh, #p < 0.05 vs. PH.
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Hepatic NPCs encompassing endothelial cells, Kupffer cells/macrophages and stellate cells are critical players 
in liver regeneration after PH. A recent work showed that when rats were injected with gliotoxin to induce liver 
NPCs death, mitosis in hepatocytes was absent 24 h after PH44. This finding certainly indicates that although 
hepatocytes themselves are fully capable of repopulating the liver after PH, hepatic NPCs are also required for 
Figure 7. Analysis of NPCs apoptosis 24 h post-PH. Apoptosis was assessed by (a) AnnexinV/propidium 
iodide staining, (b) caspase-3 activity, and (c) immunoblotting study of active caspase-3. Selected lanes were 
cropped from different parts of the same gel and they are shown after cropping, aligning and separating them 
by white space. Full-length blots are available in Supplementary Information. Sh: sham animals, PH: partial-
hepatectomized animals treated with vehicle, PHZi: PH-animals treated with zileuton 40 mg/Kg body weight. 
Bars represent mean ± SEM (n = 4 per experimental group). *p < 0.05 vs. Sh, #p < 0.05 vs. PH.
1 2Scientific RepoRtS |         (2019) 9:18176  | https://doi.org/10.1038/s41598-019-54652-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
proper restoration of liver mass. Several lines of evidence demonstrated that Kupffer cells/macrophages activa-
tion is beneficial to liver regeneration and provides the initial priming force for hepatocyte proliferation45. Liver 
macrophages have been classified into two subsets: resident CD68+ Kupffer cells with phagocytic and bacte-
ricidal activities and recruited CD11b+ Kupffer cells/macrophages with cytokine-producing capacity. Among 
these populations, after a PH in mice, CD68+ Kupffer cells decreased and CD11b+ Kupffer cells/macrophages 
recruited from the periphery and bone marrow increased46. In our study, a reduction in CD68 protein levels and 
an increment in CD11b together with a decrease in CLEC4F, a specific marker of resident Kupffer cells32, were 
observed 24 h post-PH. Interestingly, treatment with zileuton significantly reduced CD68 and CD11b markers 
as well as CLEC4F expression in NPCs. Collectively, these results indicate that inhibition of 5-LOX by zileuton 
affected Kupffer cells/macrophages population and this fact can have a clear impact on the regenerative process. 
Of all the liver NPCs, Kupffer cells are the only cells that possess a metabolically active 5-LOX pathway and it was 
demonstrated that inhibition of 5-LOX pathway reduces Kupffer cells growth and induces apoptosis, indicating 
that a metabolically active 5-LOX pathway is critical for the survival of these cells7,34. In line with this, NPCs from 
zileuton-treated hepatectomized rats showed higher apoptosis than NPCs from control PH–rats. Strikingly, apop-
tosis of NPCs was significantly reduced 24 h after hepatectomy. This reduction could be important in preserving 
NPCs for the regenerative process and, as zileuton increased apoptosis levels to those of sham animals, it cannot 
be discarded that this mechanism is also operating in the delay of regeneration when 5-LOX pathway is inhibited. 
Additionally, it was reported that NPCs, particularly endothelial cells and macrophages, are the major source of 
Wnts during liver regeneration47. As NPCs were affected by zileuton treatment, this fact can directly impact on 
the activation of Wnt/β-catenin signaling. Future studies could focus on deepening these findings.
Conclusions
The present work provides certain evidences that 5-LOX activation and its product LTB4 are involved in the 
initial signaling events for liver regeneration after PH. In fact, it can be stated that enzymes of the eicosanoids syn-
thesis are differentially expressed during the time-course of liver regeneration. While COX-2 products are crucial 
at longer times post-PH as was previously established39, 5-LOX product, LTB4, is an important signaling mediator 
for liver regeneration at earlier times. Additionally, we provide evidences that the use of zileuton may affect liver 
regeneration in situations in which tissue resection is needed. This data is important not only for a better under-
standing of the mechanisms that take place during liver regeneration but also for considering pharmacological 
situations in which liver regeneration can be affected. In fact, it was recently published that human hepatocellular 
carcinoma overexpressed 5-LOX48. So, a question emerges regarding if zileuton could be a possible therapeutic 
strategy to prevent hepatocellular carcinoma recurrence after PH for liver resection. Despite additional studies 
are necessary to completely delineate the involvement of LTB4, the present results open a new door for the better 
comprehension of the multiple mechanisms that take place during liver regeneration after PH in which hepatic 
5-LOX and LTB4 can be considered new players in the regenerative phenomenon.
Data availability
All data generated or analyzed during this study are included in this published article (and in Supplementary 
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